Keensight-backed Bedfont Scientific acquires coVita, its exclusive US distributor
Tuesday, October 13, 2026 · first reported by PE Hub
Keensight Capital-backed Bedfont Scientific acquires coVita, its exclusive US distributor of breath analysis devices for healthcare and clinical research.
- Also named
- Bedfont Scientific, coVita
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- Rhône inks $900m Paragon Films sale to Atlantic Ridge and GrafinePE Hub
- Shore Capital sells Fund I portfolio to FCPT for $268 millionscanx.trade
- Lazard to reshuffle APAC advisory leadership following acquisition of Campbell LutyensPrivate Equity International
- Aurelius to acquire Nokia’s Enterprise Campus Edge business in carve-outPE Hub
- Asterion Industrial Partners Agreed to Acquire Fleet Leasing Group Fraikin From Benefit Street, Värde and CanyonHedgeCo Insights
- EQT broadens RE business with Platinum acquisitionFinancial Newswire +1